Susquehanna International Group, LLP Glaukos Corp Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$89.48 - $118.35 $1.41 Million - $1.87 Million	15,800 Added 36.92%	58,600 $6.94 Million
Q1 2024 May 07, 2024	SELL	$76.4 - $96.33 $114,600 - $144,495	-1,500 Reduced 3.39%	42,800 $4.04 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $2.46 Million - $3.52 Million	41,400 Added 1427.59%	44,300 $3.52 Million
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $1.32 Million - $1.51 Million	-19,100 Reduced 86.82%	2,900 $218,000
Q2 2023 Aug 11, 2023	SELL	$45.44 - $71.21 $604,352 - $947,092	-13,300 Reduced 37.68%	22,000 $1.57 Million
Q1 2023 May 16, 2023	SELL	$43.88 - $52.48 $3.08 Million - $3.68 Million	-70,200 Reduced 66.54%	35,300 $1.77 Million
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $1.5 Million - $2.12 Million	36,700 Added 53.34%	105,500 $4.61 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $852,488 - $1.06 Million	18,200 Added 35.97%	68,800 $3.66 Million

303

47M

75.3K

157K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.02B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.